385 related articles for article (PubMed ID: 19003944)
1. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
Gardin NE
Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
[TBL] [Abstract][Full Text] [Related]
2. Perioperative application of the Viscum album extract Isorel in digestive tract cancer patients.
Enesel MB; Acalovschi I; Grosu V; Sbarcea A; Rusu C; Dobre A; Weiss T; Zarkovic N
Anticancer Res; 2005; 25(6C):4583-90. PubMed ID: 16334146
[TBL] [Abstract][Full Text] [Related]
3. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
[TBL] [Abstract][Full Text] [Related]
4. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
Cebović T; Spasić S; Popović M
Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of immunological reactivity of patients with adverse effects during therapy with an aqueous mistletoe extract.
Stein GM; Berg PA
Eur J Med Res; 1999 May; 4(5):169-77. PubMed ID: 10336405
[TBL] [Abstract][Full Text] [Related]
7. Study on local inflammatory reactions and other parameters during subcutaneous mistletoe application in HIV-positive patients and HIV-negative subjects over a period of 18 weeks.
Stoss M; van Wely M; Musielsky H; Gorter RW
Arzneimittelforschung; 1999 Apr; 49(4):366-73. PubMed ID: 10337457
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cellular and humoral immune responses during exposure of healthy individuals to an aqueous mistletoe extract.
Stein GM; Berg PA
Eur J Med Res; 1998 Jun; 3(6):307-14. PubMed ID: 9620894
[TBL] [Abstract][Full Text] [Related]
9. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
Bar-Sela G; Gershony A; Haim N
Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
[TBL] [Abstract][Full Text] [Related]
10. Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy.
Kirsch A; Hajto T
J Altern Complement Med; 2011 Oct; 17(10):973-9. PubMed ID: 22010781
[TBL] [Abstract][Full Text] [Related]
11. Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines.
Radenkovic M; Ivetic V; Popovic M; Mimica-Dukic N; Veljkovic S
Phytother Res; 2006 May; 20(5):374-7. PubMed ID: 16619366
[TBL] [Abstract][Full Text] [Related]
12. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
[TBL] [Abstract][Full Text] [Related]
13. In vitro response of stimulated B-CLL lymphocytes of patients treated with Viscum album L. extracts.
Büssing A; Kochskämper H; Rieger S; Schierholz JM; Schlodder D; Schietzel M
Anticancer Res; 2007; 27(6B):4195-200. PubMed ID: 18225591
[TBL] [Abstract][Full Text] [Related]
14. High-Dose Viscum album Extract Treatment in the Prevention of Recurrent Bladder Cancer: A Retrospective Case Series.
von Schoen-Angerer T; Wilkens J; Kienle GS; Kiene H; Vagedes J
Perm J; 2015; 19(4):76-83. PubMed ID: 26517439
[TBL] [Abstract][Full Text] [Related]
15. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals.
Gorter RW; van Wely M; Reif M; Stoss M
Altern Ther Health Med; 1999 Nov; 5(6):37-44, 47-8. PubMed ID: 10550904
[TBL] [Abstract][Full Text] [Related]
16. Comparative study on the effects of aqueous extracts of viscum album (mistletoe) from three host plants on hematological parameters in albino rats.
Ladokun O; Ojezele M; Arojojoye O
Afr Health Sci; 2015 Jun; 15(2):606-12. PubMed ID: 26124810
[TBL] [Abstract][Full Text] [Related]
17. The effect of mistletoe, Viscum album coloratum, extract on innate immune response of Nile tilapia (Oreochromis niloticus).
Park KH; Choi SH
Fish Shellfish Immunol; 2012 Jun; 32(6):1016-21. PubMed ID: 22554573
[TBL] [Abstract][Full Text] [Related]
18. Immune modulation using mistletoe (Viscum album L.) extracts Iscador.
Büssing A
Arzneimittelforschung; 2006 Jun; 56(6A):508-15. PubMed ID: 16927532
[TBL] [Abstract][Full Text] [Related]
19. Immune-related and adverse drug reactions to low versus high initial doses of Viscum album L. in cancer patients.
Schad F; Thronicke A; Merkle A; Matthes H; Steele ML
Phytomedicine; 2017 Dec; 36():54-58. PubMed ID: 29157828
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
